Triple-agonists are a newer type of medication that binds to and activates three distinct receptor types simultaneouslythe goal is to achieve a stronger effect
Other pathologic features linked to effects of excessive GH may be observed, such as vertebral deformities and abnormal calcium levels, increased risk of cardiovascular disease, respiratory comorbidities, and glucose intolerance
It has also been found to raise glutathione levels
Both are classified as research peptides, and their compounding and distribution fall under FDA compounding regulations
An active Eden Membership is required to receive medication ($39 the first month, then $99/month), so the ongoing all-in cost is $198/month for semaglutide and $298/month for tirzepatide
Wang Y, Zhu J, Liu Z, Shu S, Fu Y, Liu Y, et al